Skip to main content
OpenTrials
Completed

NCT Number: NCT05364476

Development and Exploration of the Effectiveness and Feasbility of a Digital Intervention for Type 2 Diabetes Mellitus

The study is conducted to assess potential effectiveness and feasibility of a comprehensive digital intervention for people with poorly-controlled Type 2 Diabetes Mellitus (T2DM), to explore the intervention effects of a combined online and offline management for people with T2DM and ultimately to improve the accessibility of lifestyle intervention among participants with T2DM.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

EVYD Technology Limited

Singapore, 078994

About this study

The study is a single-arm, non-randomized clinical trial conducted to assess potential effectiveness and feasibility of a comprehensive digital intervention for people with poorly-controlled T2DM, to explore the 16 weeks intervention effects of a combined online and offline management for people with T2DM and ultimately to improve the accessibility of lifestyle intervention among participants with T2DM.

Primary objective is to study the proportion of participants with decrease in Hba1c by 0.6% by providing digital based lifestyle modifications. Secondary objectives include to 1) estimate the change in Hba1c, body mass index (BMI) and improvement in lipid profile components at week 16 compared with baseline readings; 2) to evaluate of the use of the Ramadan Risk Score (IDF-DAR Risk Stratification Scoring Tool); 3) to evaluate the rate of fasting and diabetes complications (hyperglycaemia / hypoglycaemia) amongst Muslims with T2DM during Ramadan.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • participants diagnosed with T2DM;
  • HbA1c 7% and above in the latest blood test valid up to 12months prior to recruitment;
  • age range between 20-70 years old;
  • BMI between 23-50kg/m2

Exclusion criteria

  • Pregnant / Breast feeding participants
  • Participants on insulin therapy or non-insulin injectable medication
  • History of diabetes crisis (hyper or hypoglycaemia) in the past 6 months
  • Blood pressure ≥ 160/100 mmHg
  • Recurrent history of acute pancreatitis
  • Decompensated liver cirrhosis
  • eGFR <60ml/min/1.73m2
  • History of acute myocardial infarction/acute coronary syndrome(within the past 1 year), arrhythmias, heart failure (NY Class II -IV)
  • Proliferative diabetic retinopathy-Foot ulcer, gangrene
  • Deep vein thrombosis of lower limbs(within the past 12 months)
  • Intermittent claudication -History of cerebral haemorrhage or acute cerebral infarction (within the past 12 months)
  • History of active cancer
  • Post-transplant/perioperative participants(defined as planned for operation for the next 6 months)
  • History of hypo or hyperthyroidism, including subclinical states
  • Musculoskeletal injuries resulting in difficulty to perform physical activities
  • Failure to provide consent
  • Unable to perform activities of daily livings (ADLs)
  • Unable to use WhatsApp and YouTube via mobile devices, e.g. phone or tablet.

Treatment and study plan

16 weeks digital intervention

Behavioral

Participants will be enrolled into a 16-week program which consist of an online and offline support from health coaches and dietitian. Participants will be given diet and exercise recommendations and lesson plans on a weekly basis by the health coaches, and supported by the dietitian.

Participants will be required to log in their blood sugar levels, weight and steps daily using connected device, including glucometer, smart band and body fat weighing scale provided into the daily report card. They will also be required to manually record their meals and exercise daily in the daily report card provided upon enrollment into study. Reviews of log will be done on a weekly/biweekly interval by the health coaches.

Other names: lifestyle intervention

Primary outcomes

  1. Change of HbA1c after 16 weeks intervention

    Time frame: 16 weeks

    proportion of participants with decrease in Hba1c by 0.6% through digital intervention for lifestyle modifications after 16 weeks.

Secondary outcomes

  1. Change in body mass index (BMI)

    Time frame: 16 weeks

    changes of BMI

  2. Change in lipid profile

    Time frame: 16 weeks

    changes of lipid profile

  3. Resulting score calculated based on IDF-DAR Risk Stratification Scoring Tool

    Time frame: Baseline

    Risk of fasting based on calculated risk score by using IDF-DAR Risk Stratification Scoring tool at baseline for Muslim participant who intend to fast

  4. Number of Participants with diabetes complications (hypo-/hyper-glycaemia) amongst Muslims with T2DM during fasting (Ramadan)

    Time frame: Fasting period over the 16 weeks intervention period

    evaluate the number of Muslim participant experiences with diabetes complications of hypoglycaemia (defined as capillary blood glucose of < 4mmol/L) and/or hyper-glycaemia (defined as capillary blood glucose of > 16.6mmo/L).

  5. Change in EQ-5D-5L score

    Time frame: 16 weeks

    changes of EQ-5D-5L score of each dimensions i.e. Mobility, Self-care, Usual activities, pain/discomfort and anxiety/ depression, and self-rating of health from a scale 0 to 100 (0 means the worst and 100 means the best health) to assess participants' health related quality of life (QOL)

Sponsors and collaborators

Lead sponsor

EVYD Technology

Industry

Collaborators

  • Raja Isteri Pengiran Anak Saleha Hospital

Registry information

Official study title

Development and Exploration of the Effectiveness and Feasbility of a Digital Intervention for Type 2 Diabetes Mellitus (DEsireD)- a Clinical Non-randomised Pilot Trial in Brunei Darussalam

Acronym: DEsireD

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
May 6, 2022
Registry last updated
Jul 28, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.